EUVIMEDEUVIMED entdecken
Korrektur

Corrigendum to Osteoarthritis risk associated with romosozumab compared with teriparatide in individuals with osteoporosis: A target trial emulation study Ann Rheum Dis 2025;84(11):1938-1947

Masaki Hatano, Yusuke Sasabuchi, Akira Okada, Yuya Kimura, Hisatoshi Ishikura, Takeyuki Tanaka, Taku Saito, Sakae Tanaka, Hideo Yasunaga

Annals of the Rheumatic Diseases · 2026-11 · 85 (11) · e135

DOI: 10.1016/j.ard.2026.04.004 ↗

Kurz gefasst

Korrektur in der Zeitschrift Annals of the Rheumatic Diseases, 2026-11. Verfasst von Masaki Hatano und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan. Electronic address: h-masak….

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan. Electronic address: h-masaki@g.ecc.u-tokyo.ac.jp.
  • Department of Real-world Evidence, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of Prevention of Diabetes and Lifestyle-Related Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of Health Services Research, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.

Zitieren

APA

Hatano, M., Sasabuchi, Y., Okada, A., Kimura, Y., Ishikura, H., Tanaka, T., Saito, T., Tanaka, S., & Yasunaga, H. (2026). Corrigendum to Osteoarthritis risk associated with romosozumab compared with teriparatide in individuals with osteoporosis: A target trial emulation study Ann Rheum Dis 2025;84(11):1938-1947. Annals of the Rheumatic Diseases, 85(11), e135. https://doi.org/10.1016/j.ard.2026.04.004

Vancouver

Hatano M, Sasabuchi Y, Okada A, Kimura Y, Ishikura H, Tanaka T, et al. Corrigendum to Osteoarthritis risk associated with romosozumab compared with teriparatide in individuals with osteoporosis: A target trial emulation study Ann Rheum Dis 2025;84(11):1938-1947. Annals of the Rheumatic Diseases. 2026;85(11):e135. doi:10.1016/j.ard.2026.04.004

BibTeX
@article{Hatano2026,
  author = {Hatano, Masaki and Sasabuchi, Yusuke and Okada, Akira and Kimura, Yuya and Ishikura, Hisatoshi and Tanaka, Takeyuki and Saito, Taku and Tanaka, Sakae and Yasunaga, Hideo},
  title = {Corrigendum to Osteoarthritis risk associated with romosozumab compared with teriparatide in individuals with osteoporosis: A target trial emulation study Ann Rheum Dis 2025;84(11):1938-1947},
  journal = {Annals of the Rheumatic Diseases},
  year = {2026},
  volume = {85},
  number = {11},
  pages = {e135},
  doi = {10.1016/j.ard.2026.04.004}
}
Kostenlos starten →